Clinical Trial Update: Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)

View source ↗

Summary

A clinical trial is investigating liver X receptor (LXR) as a novel therapeutic target for diabetic retinopathy and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• LXR-targeted therapy (not specified)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Diabetic Retinopathy | Status: RECRUITING